Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol

NCT04453839 is registered in ClinicalTrials.gov with APR Applied Pharma Research s.a. as lead sponsor.

NCT NCT04453839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04453839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol
Lead sponsor
APR Applied Pharma Research s.a.
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

critical covid-19 with respiratory failure